Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Subcutaneous injection of Lederspan |
Direct substance |
False |
Triamcinolone hexacetonide (substance) |
Inferred relationship |
Some |
|
Triamcinolone hexacetonide 5mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone hexacetonide (substance) |
Inferred relationship |
Some |
|
Triamcinolone hexacetonide 20mg/mL injection suspension 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone hexacetonide (substance) |
Inferred relationship |
Some |
|
hexacétonide de triamcinolone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone hexacetonide (substance) |
Inferred relationship |
Some |
|
Subcutaneous injection of triamcinolone hexacetonide |
Direct substance |
True |
Triamcinolone hexacetonide (substance) |
Inferred relationship |
Some |
1 |
Injection of triamcinolone hexacetonide into knee joint |
Direct substance |
True |
Triamcinolone hexacetonide (substance) |
Inferred relationship |
Some |
1 |
Injection of triamcinolone hexacetonide into ankle joint (procedure) |
Direct substance |
True |
Triamcinolone hexacetonide (substance) |
Inferred relationship |
Some |
1 |
Injection of triamcinolone hexacetonide into shoulder joint |
Direct substance |
True |
Triamcinolone hexacetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone hexacetonide 100 milligram/5 milliliter conventional release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Triamcinolone hexacetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone hexacetonide 100 milligram/5 milliliter conventional release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Triamcinolone hexacetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone hexacetonide 20 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone hexacetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone hexacetonide 20 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone hexacetonide (substance) |
Inferred relationship |
Some |
1 |